Display options
Cite
Teitelbaum D, Aharoni R, Sela M, et al. Cross-reactions and specificities of monoclonal antibodies against myelin basic protein and against the synthetic copolymer 1. Proc Natl Acad Sci U S A. 1991;88(21):9528-32doi: 10.1073/pnas.88.21.9528.
Teitelbaum, D., Aharoni, R., Sela, M., & Arnon, R. (1991). Cross-reactions and specificities of monoclonal antibodies against myelin basic protein and against the synthetic copolymer 1. Proceedings of the National Academy of Sciences of the United States of America, 88(21), 9528-32. https://doi.org/10.1073/pnas.88.21.9528
Teitelbaum, D, et al. "Cross-reactions and specificities of monoclonal antibodies against myelin basic protein and against the synthetic copolymer 1." Proceedings of the National Academy of Sciences of the United States of America vol. 88,21 (1991): 9528-32. doi: https://doi.org/10.1073/pnas.88.21.9528
Teitelbaum D, Aharoni R, Sela M, Arnon R. Cross-reactions and specificities of monoclonal antibodies against myelin basic protein and against the synthetic copolymer 1. Proc Natl Acad Sci U S A. 1991 Nov 01;88(21):9528-32. doi: 10.1073/pnas.88.21.9528. PMID: 1719533; PMCID: PMC52751.
Copy Download .nbib Format: NLM
Share it on
Full text links
HighWire Free PMC Article

Proc Natl Acad Sci U S A. 1991 Nov 01;88(21):9528-32. doi: 10.1073/pnas.88.21.9528.

Cross-reactions and specificities of monoclonal antibodies against myelin basic protein and against the synthetic copolymer 1.

Proceedings of the National Academy of Sciences of the United States of America

D Teitelbaum, R Aharoni, M Sela, R Arnon

Affiliations

  1. Department of Chemical Immunology, Weizmann Institute of Science, Rehovot, Israel.

PMID: 1719533 PMCID: PMC52751 DOI: 10.1073/pnas.88.21.9528
Free PMC Article

Abstract

Antibody cross-reactivity is here demonstrated between basic protein (BP), the encephalitogenic molecule of myelin, and copolymer 1 (Cop 1), the synthetic amino acid copolymer, which has a suppressive effect on experimental allergic encephalomyelitis and is effective in reducing the number of relapses in exacerbating-remitting multiple sclerosis. This cross-reactivity is conclusively established using mouse monoclonal antibodies (mAbs). About a third of anti-rat BP mAbs and most of anti-mouse BP mAbs cross-reacted with Cop 1. This cross-reactivity could be demonstrated with anti-BP mAbs of different specificities. In addition, several anti-Cop 1 hybridomas cross-reacted with BP. This cross-reactivity was verified in several assay systems, including competitive inhibition experiments. Moreover, some anti-BP mAbs and anti-Cop 1 mAbs reacted in a heteroclitic manner and favored the cross-reactive antigen over the immunogen. In contrast to the mAbs, no cross-reactivity could be demonstrated with the antisera of immunized mice. This observation may reflect the different B-cell populations expressed in the mAb response as compared to the polyclonal response. Thus, the use of mAbs has uncovered specificities that are not evident in antisera and has revealed pronounced cross-reactivity between BP and Cop 1 at the B-cell level. These results further establish the immunological interrelationships between Cop 1 and BP, demonstrated earlier at the T-cell level.

Similar articles

Cited by

References

  1. Immunochemistry. 1976 Apr;13(4):333-7 - PubMed
  2. Eur J Immunol. 1973 May;3(5):273-9 - PubMed
  3. FEBS Lett. 1970 May 1;7(4):317-320 - PubMed
  4. Eur J Immunol. 1971 Aug;1(4):242-8 - PubMed
  5. Proc Natl Acad Sci U S A. 1983 May;80(9):2723-7 - PubMed
  6. Immunology. 1990 Aug;70(4):527-34 - PubMed
  7. Clin Immunol Immunopathol. 1974 Nov;3(2):256-62 - PubMed
  8. Nature. 1990 Jul 12;346(6280):183-7 - PubMed
  9. J Exp Med. 1982 Nov 1;156(5):1352-65 - PubMed
  10. Science. 1990 Feb 9;247(4943):718-21 - PubMed
  11. Biochem J. 1989 Jan 15;257(2):535-40 - PubMed
  12. Proc Natl Acad Sci U S A. 1988 Dec;85(24):9724-8 - PubMed
  13. Eur J Immunol. 1973 May;3(5):279-86 - PubMed
  14. J Immunol. 1979 Nov;123(5):2156-60 - PubMed
  15. Cell Immunol. 1982 Sep 15;72(2):360-6 - PubMed
  16. J Exp Med. 1991 Jan 1;173(1):19-24 - PubMed
  17. N Engl J Med. 1987 Aug 13;317(7):408-14 - PubMed
  18. J Neuroimmunol. 1986 Feb;10(4):289-312 - PubMed
  19. Curr Top Microbiol Immunol. 1978;81:130-9 - PubMed
  20. Biochem J. 1963 Oct;89:114-23 - PubMed
  21. Annu Rev Immunol. 1990;8:579-621 - PubMed
  22. Clin Immunol Rev. 1981-1982;1(4):581-697 - PubMed

Substances

MeSH terms

Publication Types

LinkOut - more resources